Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: mechanisms of initiation, progression, and drug sensitivity

MK Mahabady, S Mirzaei, H Saebfar… - Journal of Cellular …, 2022 - Wiley Online Library
The identification of agents that can reverse drug resistance in cancer chemotherapy, and
enhance the overall efficacy is of great interest. Paclitaxel (PTX) belongs to taxane family …

Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity.

MK Mahabady, S Mirzaei, H Saebfar… - Journal of Cellular …, 2022 - europepmc.org
The identification of agents that can reverse drug resistance in cancer chemotherapy, and
enhance the overall efficacy is of great interest. Paclitaxel (PTX) belongs to taxane family …

Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity

MK Mahabady, S Mirzaei, H Saebfar… - Journal of Cellular …, 2022 - pure.uj.ac.za
The identification of agents that can reverse drug resistance in cancer chemotherapy, and
enhance the overall efficacy is of great interest. Paclitaxel (PTX) belongs to taxane family …

[PDF][PDF] Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity

MK Mahabady, S Mirzaei, H Saebfar, MH Gholami… - ertaslab.com
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation,
progression, and drug sensitivity Page 1 Received: 10 July 2021 | Accepted: 19 January 2022 …

Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity

M Mahabady, S Mirzaei, H Saebfar… - JOURNAL OF …, 2022 - avesis.erciyes.edu.tr
The identification of agents that can reverse drug resistance in cancer chemotherapy, and
enhance the overall efficacy is of great interest. Paclitaxel (PTX) belongs to taxane family …

Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity

MK Mahabady, S Mirzaei, H Saebfar… - Journal of cellular …, 2022 - pubmed.ncbi.nlm.nih.gov
The identification of agents that can reverse drug resistance in cancer chemotherapy, and
enhance the overall efficacy is of great interest. Paclitaxel (PTX) belongs to taxane family …

[PDF][PDF] Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity

MK Mahabady, S Mirzaei, H Saebfar, MH Gholami… - researchgate.net
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation,
progression, and drug sensitivity Page 1 Received: 10 July 2021 | Accepted: 19 January 2022 …